Brian V. Burke, MD; Sandra Hedin, PharmD
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-1482.
Corresponding Author: Brian V. Burke, MD, Dayton VA Medical Center, 4100 West 3rd Street, Routing #11C, Dayton, OH 45428; e-mail, email@example.com.
Current Author Addresses: Dr. Burke: 4100 West 3rd Street, Routing #11C, Dayton, OH 45419.
Dr. Hedin: 5000 South 5th Street, Pharmacy 119, Hines, IL 60141.
Author Contributions: Drafting of the article: B.V. Burke, S. Hedin.
Final approval of the article: B.V. Burke, S. Hedin.
Burke BV, Hedin S. Brief Commentary: Laboratory Accuracy of Hemoglobin A1c Ranges and Treatment Targets for Patients With Type 2 Diabetes. Ann Intern Med. 2018;169:254–255. [Epub ahead of print 26 June 2018]. doi: https://doi.org/10.7326/M18-1482
Download citation file:
Published: Ann Intern Med. 2018;169(4):254-255.
Published at www.annals.org on 26 June 2018
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use